Skip to main content


designed to fit the patient's unique anatomy


Some call it conformability.
We call it one less thing for you to worry about.

Device conformability can reduce complications in patients with aortic disease requiring reintervention.1-3 That is why we design our aortic devices to adapt to the patient's unique anatomy.

At Gore, our portfolio of conformable stent grafts and innovative delivery systems allows us to support physicians in improving clinical outcomes in EVAR and TEVAR procedures, providing what matters to the patients´: Long-lasting treatment.


Aortic endoprosthesis designed to respect the anatomy

Gore strives to redefine the standard of conformability. A device achieves conformability by combining radial force, device flexibility and spring-back force.

The GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System exhibited exceptional conformability based on results of spring-back analysis.

See full comparison



Elements of conformability

Low tendency to spring back
Exceptional flexibility while maintaining an open lumen
Designed to adapt to the anatomy

Endovascular aortic repair devices to provide controlled conformability

Controlled conformability for each patient – building on the proven performance of the GORE® EXCLUDER® Device family, i.e. the conformable stent graft and innovative delivery system, offers new levels of control.

Learn more about the only EVAR device with angulation control



“Gore has combined a stent design, device conformability and
an enhanced delivery system to give physicians even more control when we need it most.”

(Dr. Robert Rhee, Chief of Vascular and Endovascular Surgery,
Maimonides Medical Center in Brooklyn, New York, National Principal Investigator)



Most studied EVAR and TEVAR devices

We are a world leader in membrane technology and biomaterials and we are dedicated to creating durable quality that is built to last, to help give patients back their quality time. By undertaking comprehensive quality assessments, we develop trusted aortic solutions used in 675,000+ devices worldwide.* Our EVAR and TEVAR devices are the most studied worldwide†,‡ - a proven and durable option to treat patients.

Most studied EVAR and TEVAR devices graphic
675,000+ devices distributed worldwide*

GORE® TAG® Conformable Thoracic Stent Graft
Anatomy through five-year follow-up3

One-year follow-up
Two-year follow-up
Three-year follow-up
Four-year follow-up
Five-year follow-up

Conformable AAA Endoprosthesis§

Twelve-month follow-up

Iliac Branch Endoprosthesis§

48-month follow-up



25 YEARS Your Aortic Ally

A focus on the future, driven by a powerful past

At Gore, we have a strong heritage in material science leadership. Since the late 60, Gore has been diving deep into material innovations and more for than 25 years, our devices are setting the standards for aortic care. But we have not stopped there. We continue to drive aortic innovations that will help physicians deliver the best possible care to their patients.
We’re your aortic ally.



Endografts designed to treat both straightforward and challenging anatomies

Our family of EVAR and TEVAR devices is designed for everyday practice and the treatment of highly challenging aortic pathologies. They all have one goal in common: Advancing aortic treatment capabilities.

GORE® TAG® Conformable Thoracic Stent Graft

New levels of control in the endovascular repair of aneurysms, transections and Type B dissections of the thoracic aorta
Learn more

GORE® EXCLUDER® Conformable AAA Endoprosthesis

Deliver angulation, controlled conformability and precise placement in challenging proximal aortic necks
Learn more




The GORE® ACTIVE CONTROL System is designed to increase the physician's confidence in deployment. It allows accurate device positioning and location refinement before full deployment and continuous blood flow throughout the entire procedure.

* Data on file, W. L. Gore & Associates, Inc; Flagstaff, AZ.

† Based on company-sponsored trials and registries shown on for currently available stent grafts.

‡ 10 FDA approved clinical studies.

§ Images from actual case study.

  1. Incidence and outcomes after infolding or collapse of thoracic stent grafts Kasirajan, Karthikeshwar et al. Journal of Vascular Surgery, Volume 55, Issue 3, 652 - 658.
  2. New C-TAG device overcome of compression events K. Kasirajan Journal of Cardiovascular Surgery, Volume 53, No. 2, 169-172.XX
  3. Donas KP, Inchingolo M, Cao P, et al; pELVIS Registry Collaborators. Secondary procedures following iliac branch device treatment of aneurysms involving the iliac bifurcation: The pELVIS Registry. Journal of Endovascular Therapy 2017;24(3):405-410.